Reviewing Tenon Medical (NASDAQ:TNON) and SiBone (NASDAQ:SIBN)

Tenon Medical (NASDAQ:TNON) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk.

Profitability

This table compares Tenon Medical and SiBone’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-396.26%	-409.04%	-114.60%
SiBone	-11.24%	-12.86%	-9.43%

Volatility and Risk

Tenon Medical has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500.

Insider and Institutional Ownership

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 0.3% of Tenon Medical shares are held by insiders. Comparatively, 3.9% of SiBone shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations for Tenon Medical and SiBone, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1	0	2	0	2.33
SiBone	1	0	5	0	2.67

Tenon Medical presently has a consensus price target of $3.00, indicating a potential upside of 180.37%. SiBone has a consensus price target of $25.00, indicating a potential upside of 22.79%. Given Tenon Medical’s higher probable upside, equities analysts plainly believe Tenon Medical is more favorable than SiBone.

Valuation and Earnings

This table compares Tenon Medical and SiBone”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.28 million	3.62	-$13.67 million	($1.77)	-0.60
SiBone	$167.18 million	5.28	-$30.91 million	($0.51)	-39.92

Tenon Medical has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Summary

SiBone beats Tenon Medical on 10 of the 14 factors compared between the two stocks.

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About SiBone

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.